Vascular inflammation in hypertension and diabetes: molecular mechanisms and therapeutic interventions
The DOI matches its Crossref record; 129 of the 129 references it cites were found in a registry or an index.
Abstract
More than 80% of patients with type 2 diabetes mellitus develop hypertension, and approx. 20% of patients with hypertension develop diabetes. This combination of cardiovascular risk factors will account for a large proportion of cardiovascular morbidity and mortality. Lowering elevated blood pressure in diabetic hypertensive individuals decreases cardiovascular events. In patients with hypertension and diabetes, the pathophysiology of cardiovascular disease is multifactorial, but recent evidence points toward the presence of an important component dependent on a low-grade inflammatory process. Angiotensin II may be to a large degree responsible for triggering vascular inflammation by inducing oxidative stress, resulting in up-regulation of pro-inflammatory transcription factors such as NF-κB (nuclear factor κB). These, in turn, regulate the generation of inflammatory mediators that lead to endothelial dysfunction and vascular injury. Inflammatory markers (e.g. C-reactive protein, chemokines and adhesion molecules) are increased in patients with hypertension and metabolic disorders, and predict the development of cardiovascular disease. Lifestyle modification and pharmacological approaches (such as drugs that target the renin–angiotensin system) may reduce blood pressure and inflammation in patients with hypertension and metabolic disorders, which will reduce cardiovascular risk, development of diabetes and cardiovascular morbidity and mortality.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“ACE-I/ARBs are typically prescribed to decrease blood pressure and sympathetic activity (Savoia and Schiffrin, 2007).”
From Inflammation in Fear- and Anxiety-Based Disorders: PTSD, GAD, and Beyond (2017) · cites this paper as Savoia and Schiffrin, 2007
In the citing paper
“there is considerable evidence that its underlying cause is inflammatory in nature [678-686]”
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections
King, H., Aubert, R. E., & Herman, W. H. (1998) · Diabetes Care · doi:10.2337/diacare.21.9.1414 · Cited by 6,311
Stearne, M. R., Palmer, S. L., Hammersley, M. S., Franklin, S. L., Spivey, R. S., Lévy, J., Tidy, C. R., Bell, N. J., Steemson, J., Barrow, B. A., et al. (1998) · UCL Discovery (University College London) · Cited by 6,090
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
Stamler, J., Vaccaro, O., Neaton, J. D., Wentworth, D., & The Multiple Risk Factor Intervention Trial Research Group (1993) · Diabetes Care · doi:10.2337/diacare.16.2.434 · Cited by 4,063
PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
Jiang, C., Ting, A. T., & Seed, B. (1998) · Nature · doi:10.1038/34184 · Cited by 2,899
Research works printed but not linked: 1
- Schöbeck, 2004, Inflammation, immunity, and HMG-CoA reductase inhibitors statins as anti-inflammatory agents?, Circulation, 109, II18
Cited by
Items 201–300 of 332
Radwan, E., Belmadani, S., & Matrougui, K. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s369488 · Cited by 12
Musial, D. C., Bomfim, G. H. S., Arranz‐Tagarro, J. A., Méndez‐López, I., Miranda‐Ferreira, R., Jurkiewicz, A., Jurkiewicz, N. H., García, A. G., & Padín, J. F. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.09.045 · Cited by 12
“Furthermore, in a latter study, vascular inflammation has been observed to be present in hypertension and diabetes (Savoia and Schiffrin, 2007).”
BackgroundAssessment of Cardiovascular Risk Factors in Patients with Type 2 Diabetes in Upper Egypt Villages
Hussein, A. A., Mahmoud, S. E. D., Awad, M. S., & Mahmoud, H. E. M. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s282888 · Cited by 14
Aldosterone levels and inflammatory stimulation in essential hypertensive patients
Tzamou, V., Vyssoulis, G. P., Karpanou, E., Kyvelou, S.-M., Gialernios, T. P., & Stefanadis, C. (2013) · Journal of Human Hypertension · doi:10.1038/jhh.2013.13 · Cited by 12
van der Zijl, N. J., Serné, E. H., Goossens, G. H., Moors, C. C. M., IJzerman, R. G., Blaak, E. E., & Diamant, M. (2011) · Journal of Hypertension · doi:10.1097/hjh.0b013e32834a7667 · Cited by 12
The Role of Antiplatelets in Hypertension and Diabetes Mellitus
Ajjan, R., & Grant, P. J. (2011) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2011.00431.x · Cited by 12
Diabetic cardiomyopathy: is resistin a culprit?
Lebeche, D. (2015) · PubMed · doi:10.3978/j.issn.2223-3652.2015.05.04 · Cited by 13
“This is of particular interest as hyperresistinemia is associated with hypertension in patients with T2DM but not non-diabetic subjects (33), while hypertension and neuro-hormonal abnormalities constitute major diabetesrelated comorbidities with nearly 80% of T2DM patients developing hypertension (34).”
BackgroundMilieu of Diabetes in the 2nd Decade of 21st Century
Suneja, S., Christian, Y., & Chandra, N. C. (2018) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000804 · Cited by 12
“Angiotensin II, produced in the same cascade, is largely responsible to trigger vascular inflammation and oxidative stress [126].”
BackgroundGainfort, A., Delahunt, A., Killeen, S. L., O'Reilly, S. L., Hébert, J. R., Shivappa, N., & McAuliffe, F. M. (2023) · AJOG Global Reports · doi:10.1016/j.xagr.2023.100214 · Cited by 11
Angiotensin‐Converting Enzyme Inhibitors in the Treatment of Hypertension: An Update
White, W. B. (2007) · Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2007.07782.x · Cited by 14
Lockhart, C., McCann, A. J., Pinnock, R. A., Hamilton, P., Harbinson, M., & McVeigh, G. E. (2014) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00372.2014 · Cited by 10
Raman, S., Sankar, D., Ali, A., Uehara, Y., Abe, S., Sambandam, G., & Rao, M. R. (2011) · Clinical and Experimental Hypertension · doi:10.3109/10641963.2010.549259 · Cited by 10
“published in which CRP predicted the development of cardiovascular disease (34, 35).”
BackgroundPlasma Vasoprotective Eicosanoid Concentrations in Healthy Greyhounds and Non-Greyhound Dogs
Martinez, J. T., Rogers, L., Kellogg, C., Iazbik, M. C., Couto, C. G., Pressler, B. M., Hoepf, T. M., & Radin, M. J. (2016) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.13833 · Cited by 10
“Vascular dysfunction is characterized by impaired vasomotor response, increased vascular permeability, endothelial cell proliferation, inflammation, and platelet adhesion and aggregation.(6) Hypertension and loss of glomerular permselectivity are recognized manifestaFrom the Department of Veterinary Biosciences, Ohio…”
BackgroundResultSousa, A., Jardim, T., Costa, T., Magalhães, F., Montelo, M. P. M., Souza, W. K. B., Jardim, P., & Sousa, A. L. (2017) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-017-0296-z · Cited by 10
“When T2DM is associated with HTN, the risk of developing CVD becomes even greater [5].”
BackgroundHaruhara, K., Wakui, H., Azushima, K., Kurotaki, D., Kawase, W., Uneda, K., Haku, S., Kobayashi, R., Ohki, K., Kinguchi, S., et al. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.01.013 · Cited by 10
Górska, D., Dudarewicz, M., Czarnecka, E., & Andrzejczak, D. (2010) · Pharmacological Reports · doi:10.1016/s1734-1140(10)70245-0 · Cited by 10
“In our studies, proinflammatory cytokines (TNF- , IL-1 and IL-6) were chosen as markers of endothelial dysfunction [28, 37].”
BackgroundKim, H. Y., & Kim, H. S. (2015) · Cytokine · doi:10.1016/j.cyto.2015.09.002 · Cited by 9
Jeong, S. J., Han, S. H., Kim, C. O., Choi, J. Y., Song, Y. G., & Kim, J. M. (2014) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.12428 · Cited by 9
Brown, D. E., Mautz, W. J., Warrington, M. H., Allen, L., Tefft, H. A. T., Gotshalk, L. A., & Katzmarzyk, P. T. (2010) · American Journal of Human Biology · doi:10.1002/ajhb.21064 · Cited by 9
“…et al., 2001; Rohde et al., 1999) and children (Giuliano et al., 2009; Kelishadi et al., 2007), and they are also linked with growth of atherosclerotic plaques (Savoia and Schiffrin, 2007) through association with markers of endothelial dysfunction such as tissue plasminogen activator.”
BackgroundLi, M., Dai, X., Watts, S. W., Kreulen, D. L., & Fink, G. D. (2008) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00783.2007 · Cited by 9
“We believe venoconstriction contributes to S6c-induced hypertension, because in vitro S6c has been shown to constrict veins from most vascular regions but to have little effect on most arteries (15, 27, 41, 49).”
BackgroundCerebral Vascular Dysfunction with Aging
Faraci, F. M. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-378638-8.00019-1 · Cited by 9
Angiotensin AT1 Receptors and Their Ligands (Review)
Спасов, А. А., Yakovlev, D. S., & Brigadirova, A. A. (2017) · Pharmaceutical Chemistry Journal · doi:10.1007/s11094-017-1546-y · Cited by 9
van Heerebeek, L. (2014) · SOJ Pharmacy & Pharmaceutical Sciences · doi:10.15226/2374-6866/1/2/00112 · Cited by 11
“Endothelial dysfunction is characterized by impaired vasomotor response, cell proliferation, platelet adhesion/aggregation, vascular permeability and leucocyte-endothelial interactions that participate in vascular inflammation [42].”
BackgroundNatural History of Treated and Untreated Hypertension
Volpe, M., & Savoia, C. (2018) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-319-59918-2_4 · Cited by 8
Self-citationDiabetes mellitus is associated with high sleep-time systolic blood pressure and non-dipping pattern
Aung, A. T., Chan, S. P., Kyaing, T.-T., & Lee, C. (2020) · Postgraduate Medicine · doi:10.1080/00325481.2020.1745537 · Cited by 9
“A majority of patients with DM have comorbid hypertension [3], which is the strongest driver underlying the progression of DM-related complications such as retinopathy, nephropathy, acute coronary syndrome, and stroke.”
BackgroundAl‐Daghri, N. M., Dahman, L. S. B., Al-Attas, O. S., Saleem, T. H., Alokail, M. S., Alkharfy, K. M., Draz, H. M., Yakout, S. M., Mohamed, A. O., Harte, A. L., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051255 · Cited by 8
“Furthermore AT derived ANG II drains directly into the circulation and is known to affect vascular pathophysiology being able to trigger vascular inflammation as well as oxidative stress [12,25,26].”
BackgroundTouyz, R. M., & Burger, D. E. (2012) · Springer eBooks · doi:10.1007/978-88-470-2601-8_19 · Cited by 8
“Both hypertension and endothelial dysfunction are also frequently accompanied by the presence of persistent, low-grade inflammation [44].”
BackgroundAykut, G., Kilercik, M., Arıtürk, C., Ulugöl, H., Aksu, U., Kudsioğlu, T., Atalan, N., Yapıcı, N., Karabulut, H., & Toraman, F. (2017) · Journal of Nephrology · doi:10.1007/s40620-017-0388-8 · Cited by 8
“Furthermore, there is considerable evidence to suggest that insulin resistance and hyperglycemia, acting via oxidative stress, inflammation and advanced glycation end products can induce microvascular abnormality [24].”
BackgroundDiabetes mellitus in a 50-year-old captive Asian elephant (Elaphas maximus) bull
van der Kolk, J. H., Hoyer, M. J., Verstappen, F., Wolters, M., Treskes, M., Grinwis, G. C. M., & Kik, M. J. L. (2011) · Veterinary Quarterly · doi:10.1080/01652176.2011.585793 · Cited by 9
Angiotensin II receptor antagonists in acute coronary syndromes
Artom, N., Montecucco, F., Mach, F., Dallegri, F., & Pende, A. (2013) · European Journal of Clinical Investigation · doi:10.1111/eci.12198 · Cited by 8
Localized pressure stimulation using turf‐like structures can improve skin perfusion in the foot
Behforootan, S., Chatzistergos, P., Chockalingam, N., Healy, A., & Naemi, R. (2019) · Microcirculation · doi:10.1111/micc.12543 · Cited by 7
“There is an increasing awareness that insulin resistance and hyperglycemia in diabetic patients can induce microvascular abnormalities [18,19].”
Backgroundvan der Velde, A. R., Meijers, W. C., & de Boer, R. A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800687-0.00018-9 · Cited by 7
Jatoi, N.-A., Elamin, Y., Said, A. H., Al-Namer, B., Al-Muallim, F. A., Al-Nemer, F. F., & Al-Halal, F. M. (2022) · Cureus · doi:10.7759/cureus.29489 · Cited by 7
“This link might be attributed to the presence of shared risk factors and inflammatory processes seen in both HTN and hyperglycemia [17,25].”
BackgroundWang, Z., Cao, C., Pan, F., Sharma, S., & Wu, J. (2025) · Food Chemistry · doi:10.1016/j.foodchem.2025.147664 · Cited by 6
Ciuceis, C. D., Flati, V., Rossini, C., Rufo, A., Porteri, E., Gregorio, J. D., Petroboni, B., Boria, E. L., Donini, C., Pasini, E., et al. (2014) · Blood Pressure · doi:10.3109/08037051.2014.901021 · Cited by 6
RNA Sequencing Screens the Key Genes and Pathways in a Mouse Model of HFpEF
Sun, Y., Li, J., Zhang, X., Wang, N., & Liu, Y. (2024) · Journal of Vascular Research · doi:10.1159/000539305 · Cited by 6
Yang, H., Nie, Y., Chen, Z., Ye, L., Wang, Q., & Wang, Z. (2017) · Scientific Reports · doi:10.1038/s41598-017-17068-9 · Cited by 6
A new model for chronic diseases
Diani, S. (2018) · Medical Hypotheses · doi:10.1016/j.mehy.2018.02.011 · Cited by 7
Cardiovascular Risk Factors and the Severity of COVID-19 Disease
Motaib, I., Zbiri, S., Elamari, S., Haoudar, A., Chadli, A., & Kettani, C. E. (2021) · Cureus · doi:10.7759/cureus.15486 · Cited by 6
“Patients with a higher level of cardiovascular risk may have a lower grade of vascular inflammation, which combines with the immune response induced by the virus and leads to an aggravation of the inflammatory state [19].”
BackgroundTanaka, M. H., Fukushima, N., Itamura, H., Urata, C., Yokoo, M., Ide, M., Hisatomi, T., Tomimasu, R., Sueoka, E., & Kimura, S. H. (2009) · International Journal of Hematology · doi:10.1007/s12185-009-0468-1 · Cited by 6
“are associated with elevated expression of inflammatory factors, including cytokines and adhesion molecules [9].”
BackgroundWang, Z., Peng, X., Tao, Y., Liu, Y., Liu, J., Chen, X., Wen, S., & Wu, Z. (2009) · Clinical and Experimental Hypertension · doi:10.1080/10641960902977890 · Cited by 7
“Voluminous literature supports the fact that chronic inflammation is very common (15–18) and closely related with vascular damage in EH (19,20).”
BackgroundLi, Q., Luo, S., Fan, Y., & Sun, H.-B. (2012) · Neurosciences · doi:10.17712/1658-3183.1967 · Cited by 6
Wynne, B. M., Labazi, H., Carneiro, Z. N., Tostes, R. C., & Webb, R. C. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.08.024 · Cited by 6
“…HNO is less reactive as compared to NO, which may lend HNO a superior stability against reactions with ROS or during conditions of high oxidative stress, such as hypertension (Savoia and Schiffrin, 2006, 2007; Schiffrin, 2007; Irvine et al., 2008; Paolocci and Wink, 2009; Switzer et al., 2009).”
Crosstalk between renin and arachidonic acid (and its metabolites)
Das, U. N., Hacımüftüoğlu, A., Akpınar, E., Gül, M., & El‐Aty, A. M. A. (2025) · Lipids in Health and Disease · doi:10.1186/s12944-025-02463-3 · Cited by 5
Wild blueberries and cardiometabolic health: a current review of the evidence
Johnson, S. A., Klimis‐Zacas, D. J., Basu, A., Bolling, B. W., Feresin, R. G., Hooshmand, S., Joris, P. J., Li, Z., Lila, M. A., Stull, A. J., et al. (2026) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2025.2610406 · Cited by 5
“…of activated B cells (NF-ĸB), a pro-inflammatory transcription factor, is activated by reactive oxygen species (ROS) produced by NOXs (Savoia and Schiffrin 2007). p50/p65 is the most abundant form of NFĸB, sequestered in the cytoplasm by binding to the inhibitor IκBα under normal…”
Mechanical Stress and the Arterial Wall
Schiffrin, E. L., Tedgui, A., & Lehoux, S. (2014) · Springer eBooks · doi:10.1007/978-1-4471-5198-2_9 · Cited by 6
Self-citationDurazzo, T. C., Kraybill, E. P., Stephens, L. H., May, A. C., & Meyerhoff, D. J. (2024) · Alcohol and Alcoholism · doi:10.1093/alcalc/agae055 · Cited by 4
Influence of Uric Acid on Vascular and Cognitive Functions: Evidence for an Ambivalent Relationship
Baratta, F., Moscucci, F., Ettorre, E., Bocale, R., Cicero, A. F. G., Cirillo, P., Fogacci, F., Lospinuso, I., Savoia, C., Mengozzi, A., et al. (2024) · Metabolites · doi:10.3390/metabo14110642 · Cited by 4
Self-citationWägner, A. M., Wiebe, J. C., Boronat, M., Saavedra, P., Marrero, D., Varillas, F., & Novoa, F. J. (2011) · PubMed · doi:10.3275/7325 · Cited by 5
Poitras, V. J., Bentley, R. F., Hopkins-Rosseel, D. H., LaHaye, S. A., & Tschakovsky, M. E. (2015) · Physiological Reports · doi:10.14814/phy2.12487 · Cited by 5
“For instance, up to 80% of persons with T2D also have hypertension (Savoia and Schiffrin 2007), and of those more than 65% require ≥2 medications to achieve the target blood pressure of <130/85 mmHg, with angiotensin-converting enzyme (ACE) inhibitors being the first prescribed (Sowers et al. 2001).”
BackgroundResultYin, W., Chen, P., Yeh, H., Wang, K., Hung, Y., Tseng, W., Wen, M., Wu, T.-C., Wu, C., Cheng, S., et al. (2016) · Medicine · doi:10.1097/md.0000000000003234 · Cited by 4
“It has been known that endothelial dysfunction and increased oxidative stress could be found in smokers,(27) and patients with metabolic syndrome(36) and diabetes mellitus.(37) Safety population: 92 subjects.”
BackgroundKhatib, R., Glowacki, N., Lauffenburger, J. C., Reddy, A., Dennert, K., & Triscari, D. (2023) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2023.05.012 · Cited by 4
Barre, D. E., Mizier-Barre, K. A., Griscti, O., & Hafez, K. (2019) · International Journal of Diabetes and Metabolism · doi:10.1159/000497699 · Cited by 4
Камышникова, Л. А., & Efremova, O. A. (2018) · Clinical Medicine (Russian Journal) · doi:10.18821/0023-2149-2017-95-12-1070-1076 · Cited by 7
Jia, X., Zhang, H., Sui, W., Zhao, A., & Ma, K. (2024) · Scientific Reports · doi:10.1038/s41598-024-71146-3 · Cited by 3
Senger, N., & Deshmukh, S. G. (2025) · Journal of Pharmacology and Pharmacotherapeutics · doi:10.1177/0976500x251398609 · Cited by 3
EFFECT OF COMBINATION TREATMENT OF CANDESARTAN AND CURCUMIN ON TRAUMATIC BRAIN INJURY IN MICE
Baraka, S. A. (2018) · Al-Azhar Journal of Pharmaceutical Sciences/Al-Azhar Journal of Pharmaceutical Sciences · doi:10.21608/ajps.2018.6634 · Cited by 3
“On the other hand, excessive stimulation of AT1R in the brain is associated with brain ischaemia, excessive inflammation (Saavedra, 2012), increasing oxidative stress, and endothelial dysfunction (Ozacmak et al., 2007; Savoia & Schiffrin, 2007) .”
BackgroundIs there any memory effect of blood pressure lowering in diabetes?
Paneni, F., Cosentino, F., Passerini, J., & Volpe, M. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.06.114 · Cited by 3
“In particular, antagonism of renin–angiotensin–aldosterone system (RAAS) is able to induce reverse vascular remodelling by blunting oxidative stress and inflammation in the vessel wall [5].”
BackgroundLeung, J. Y. T., & Pang, C. C. Y. (2014) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000093 · Cited by 3
“Chronic low-level inflammation is present in diabetes, as evident by the upregulation of proinflammatory cytokines and enhanced expression of COX-2, the inducible isoform of cyclooxygenase.(9,10) Activation of COX-2 has been detected in the aorta of db/db(11) and streptozotocin (STZ)-induced diabetic(12) mice, femoral…”
BackgroundRegulatory T Cells and Cardiovascular Diseases
Jevallee, H., Tang, T., & Cheng, X. C. (2011) · North American Journal of Medicine and Science · doi:10.7156/v4i4p178 · Cited by 2
Mechanisms of angiotensin II to induce depression in diabetes
Vargas, R., Pedreáñez, A. B., Carrero, Y. N., Hernández-Fonseca, J. P., Hernández–Fonseca, H., & Mosquera-Sulbarán, J. (2025) · Diabetology International · doi:10.1007/s13340-025-00817-x · Cited by 2
qian, H., Wu, C., Li, B., Rosenzweig, A., & Wang, M. (2026) · Med · doi:10.1016/j.medj.2026.101232 · Cited by 2
Kolesnyk, I. M., Kolesnyk, M., & Abramov, A. B. (2014) · Fìzìologìčnij žurnal · doi:10.15407/fz60.03.018 · Cited by 3
The Effects of Novel AMPK Activator on Human Vascular Endothelial Cells
Chen, H., Lin, J., Kuo, C., & Huang, C.-F. (2013) · Journal of Medical and Bioengineering · doi:10.12720/jomb.3.2.144-148 · Cited by 2
“Chronic vascular inflammation in diabetes may lead to cardiovascular diseases [10]-[24].”
BackgroundEffects of Ramadan fasting on cardiovascular risk factors: A narrative review
Soleimani, D., Nematy, M., Hashemi, M., & Khayyatzadeh, S. S. (2016) · DOAJ (DOAJ: Directory of Open Access Journals) · doi:10.22038/jfh.2016.8016 · Cited by 2
“The consequences of hypertension include various degenerative diseases, such as coronary artery disease, chronic kidney disease, heart failure and peripheral vascular diseases (25-27).”
BackgroundKoschate, J., Drescher, U., Baum, K., Brinkmann, C. K., Schiffer, T., Latsch, J., Brixius, K., & Hoffmann, U. (2017) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0042-119526 · Cited by 2
“T2DM is often accompanied by comorbidities such as arterial hypertension [5, 6], lipid metabolism disorders [7], overweight or obesity [8].”
Jiajing, Z., Bi, Y., Jiang, W., Qi, W., Shu-rong, G., HongJie, Y., Cao, F., Yue, Y., & Wang, Y. (2020) · Indian Journal of Pharmaceutical Sciences · doi:10.36468/pharmaceutical-sciences.spl.1 · Cited by 2
“Ang II, the most active substance of RAAS, has a strong role in vascular remodeling involving vasoconstriction and promotion of development of atherosclerosis, endothelial dysfunction, hypertension and related diseases such as metabolic syndrome, through a variety of inflammation and coagulation mechanism[29,30].”
BackgroundSavoia, C., Ciuceis, C. D., Paini, A., Carletti, R., Arrabito, E., Nicoletti, C., Mercantini, P., Gioia, C. R. T. D., Battistoni, A., Ucci, S., et al. (2020) · Journal of Hypertension · doi:10.1097/hjh.0000000000002595 · Cited by 2
“Copyright © 2020 Wolters Kluwer Journal of Hypertension function is also correlated to the positive modulation of vascular inflammation and remodeling and ultimately to the protection of the cardiovascular system [1,32].”
BackgroundSelf-citationSulforaphane and Atherosclerosis
Babu, P. V. A., Petersen, C., & Jia, Z. (2017) · Reference series in phytochemistry · doi:10.1007/978-3-319-25462-3_11 · Cited by 2
Verma, A., SUNITA, S., Yadav, A. K., Singh, C., Saxena, A., & Singh, G. (2023) · International Journal of Community Medicine and Public Health · doi:10.18203/2394-6040.ijcmph20233770 · Cited by 1
Adaptive Immune System in Hypertension: Implicating the Role of T Cells
Varadarajan, P., Sugin Lal Jabaris, S., Krishnamurthy, V., & Hemalatha, K. (2025) · Current Cardiology Reviews · doi:10.2174/011573403x387039251002064044 · Cited by 1
“Proinflammatory cytokines such as IL-6, TNF-α , and NF-κ B are inhibited by IL-10 [55-57 55-57 ].”
Increased risk of sympathetic ophthalmia in ocular surgical patients with trauma history
Hsu, A. Y., Chiang, C.-C., Shao, Y.-C., Kuo, H., Hsia, N.-Y., Lai, C., Wu, B., Tseng, H., Lin, C., Tien, P., et al. (2025) · International Ophthalmology · doi:10.1007/s10792-025-03861-3 · Cited by 1
“These comorbidities were examined because, from a pathophysiological perspective, they are characterized by systemic inflammation, which could theoretically predispose patients to SO, an intraocular inflammatory disorder [23].”
Stump, K., Centeno, D., Talsania, A. J., Morar, H., & Wiekrykas, B. D. (2026) · Hand · doi:10.1177/15589447261422503 · Cited by 1
Ramos, R. R., Ostrosky‐Wegman, P., & Cebrián, M. E. (2011) · Humana Press eBooks · doi:10.1007/978-1-60761-956-7_33 · Cited by 1
“The partial loss of the balance between endothelium-mediated vasodilation and vasoconstriction, known as vascular endothelial dysfunction, is often associated with the pathogenesis of various chronic disorders, such as atherosclerosis [27], hypertension and diabetes [ 28 ].”
BackgroundDual renin-angiotensin system blockade and vascular remodeling
Savoia, C., & Grassi, G. M. (2015) · Journal of Hypertension · doi:10.1097/hjh.0000000000000771 · Cited by 1
“Constriction may be a consequence of increased concentration of specific agents at the level of receptors including enhanced angiotensin II signaling, which leads to changes in intracellular calcium, protein kinases, diacylglycerol, and increased reactive oxygen species (ROS) generation [18,19], as well as cell growth…”
BackgroundSelf-citationUnpuzzling the Comorbid Type 2 Diabetes and Hypertension-Related Cognitive Dysfunction and Stroke
Sebastião, I., Candeias, E., Santos, M. S., Oliveira, C. R., Moreira, P. I., & Duarte, A. I. (2017) · Springer series in translational stroke research · doi:10.1007/978-3-319-45345-3_31 · Cited by 1
Mechanisms of Action of Drugs for Treating Endothelial Dysfunction in Diabetes Mellitus
Nizami, H. L., & Banerjee, S. (2017) · Springer eBooks · doi:10.1007/978-3-319-60324-7_22 · Cited by 2
Cao, F., & Ma, S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-805253-2.00008-0 · Cited by 1
Association of NFKB1 -94 ins/del variants with BMI in patients with myocardial infarction
Pordel, S., Nayebi, M., Khosropanah, S., & Doroudchi, M. (2019) · Obesity Medicine · doi:10.1016/j.obmed.2019.100098 · Cited by 1
von Degenfeld, G., & Truebel, H. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820493-1.00017-9 · Cited by 1
Vascular Changes in the Microcirculation: Arterial Remodeling and Capillary Rarefaction
Savoia, C., & Schiffrin, E. L. (2015) · Springer eBooks · doi:10.1007/978-3-319-14556-3_5 · Cited by 1
Self-citationKassan, M. (2010) · Gredos (University of Salamanca) · doi:10.14201/gredos.83206 · Cited by 1
Receptors | Angiotensin Receptors
Pardhi, T. R., & Karnik, S. S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819460-7.00096-7 · Cited by 1
“Reduction in inflammatory processes in vessel walls was observed in patients with arterial hypertension and metabolic syndrome when treated with ARBs, thus decreasing their risk for cardiovascular disease and development of diabetes mellitus (Savoia and Schiffrin, 2007).”
Papel do fator de necrose tumoral (TNF-a) na fisiopatologia da disfunção erétil.
Carneiro, F. S. (2011) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2011.tde-16082011-090246 · Cited by 2
Inhibition of Prolyl Hydroxylase Domain-Containing Protein
Takayanagi, T., & Eguchi, S. (2011) · Hypertension · doi:10.1161/hypertensionaha.111.177949
Milk casein-derived tripeptides : A special focus on blood pressure and vascular function
Ehlers, P. I. (2010) · Työväentutkimus Vuosikirja
Gender: does it have a role in blood pressure in Caucasians with well-controlled type 2 diabetes?
Barre, D. E., Mizier-Barre, K. A., Griscti, O., & Hafez, K. (2019) · International Journal of Diabetes and Metabolism · doi:10.1159/000497671
Corona, M. M., Acosta, M. B., González, R. G., & Blanco, D. R. (2015) · Revista Cubana de Alimentación y Nutrición · Cited by 14
Genetics of Cardiovascular Risk in Obesity
Blackett, P. R., & Sanghera, D. K. (2015) · Springer eBooks · doi:10.1007/978-3-319-12125-3_13-1
Interleukin-6 in obese type II diabetes with hypertension
Laishram, V., Lamabam, C., Shaini, L., Dubey, A., Longkumer, C., Sharma, S., Debnath, S., & Das, R. (2016) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20160539
Cardiovascular Health in Advanced Age
Teh, R. (2011) · ResearchSpace (University of Auckland)
Reply to ‘The enigma of micro- and macrovascular changes in mild essential hypertension’
Ciuceis, C. D., Salvetti, M., Muiesan, M. L., Rizzoni, D., & Agabiti‐Rosei, E. (2014) · Journal of Hypertension · doi:10.1097/hjh.0000000000000190
Leung, J. Y. T. (2015) · cIRcle (University of British Columbia) · doi:10.14288/1.0166166
“Effects of nimesulide, a selective COX-2 inhibitor, on cardiovascular function in 2 rat models of diabetes.”
InfluentialPathophysiology of Pediatric Hypertension
Yamaguchi, I., & Flynn, J. T. (2015) · Springer eBooks · doi:10.1007/978-3-662-43596-0_55
Lillo, A. (2011) · NORA - Norwegian Open Research Archives
Efecto de los flavonoides sobre la función endotelial en ratas con hipertensión arterial
Carreras, P., & Dolores, M. (2015) · Digitum: Institutional Repository of the University of Murcia (University of Murcia)
Modlińska-Cwalińska, A. (2014)
Sulforaphane and Atherosclerosis
Babu, P. V. A., Petersen, C., & Jia, Z. (2016) · Springer eBooks · doi:10.1007/978-3-319-26479-0_11-1
“Nuclear factor ĸB (NFĸB) is a pro-inflammatory transcription factor that plays a major role in upregulating inflammatory molecules such as chemokines and adhesion molecules [57].”
BackgroundDanovska, M., Alexandrova, M. L., & Gencheva, I. I. (2013) · Journal of Biomedical and Clinical Research · doi:10.1515/jbcr-2015-0107
Metadata
- Authors
- Savoia, C., & Schiffrin, E. L.
- Affiliations
- Jewish General Hospital (CA)
- Venue
- Clinical Science
- Publisher
- Portland Press Ltd.
- Published
- 2007-03-01
- Volume
- 112
- Issue
- 7
- Pages
- 375-384
- ISSN
- 0143-5221 (ISSN-L)
- 1470-8736
- OpenAlex
- W1975582897
- Cited by
- 326
- References
- 129
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 8 · 2023: 7 · 2022: 13 · 2021: 10 · 2020: 21 · 2019: 14 · 2018: 15 · 2017: 20 · 2016: 18 · 2015: 24 · 2014: 21 · 2013: 23 · 2012: 21
- FWCI
- 2.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Science (publishedVersion)
- PubMed (publishedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Keywords
- vascular inflammation, hypertension, type 2 diabetes, angiotensin II, oxidative stress, NF-κB, endothelial dysfunction, cardiovascular risk, C-reactive protein, chemokines, adhesion molecules, renin-angiotensin system, blood pressure reduction, lifestyle modification
- MeSH terms
- Aldosterone, Angiotensin II, Diabetes Mellitus, Type 2, Humans, Hypertension, Renin-Angiotensin System, Vasculitis, Cell Adhesion Molecules, Cytokines, NF-kappa B, Disease Progression, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.